What Digital Twins of Human Body Mean for Medicine

Digital Twins of Human Body technology is helping healthcare organisations explore how diseases develop, how patients may respond to treatments, and how medical devices perform before they are used in real clinical settings. By creating virtual representations of organs, patients, or care pathways, healthcare providers and researchers can test different scenarios and support more personalised treatment planning. The technology is also changing medical research, device development, and the way healthcare businesses approach long-term investment.

For more info: https://bi-journal.com/digital-twins-of-the-human-body/

How Digital Twins Are Changing Healthcare

A digital twin is a digital copy of a physical system that can be iteratively tuned and used to simulate various scenarios. In healthcare this can be a model of a single organ, an individual's health parameters, or the care journey. The benefit comes from being able to see what might happen before you need to make a decision clinically or making an investment.

As an example, simulators would allow researchers to investigate how a device may function in a variety of situations and clinicians could plan and compare possible treatment strategies. This technology is no longer confined to research. Industry leaders including Dassault Systèmes, Siemens Healthineers, and Philips are creating virtual twin functionality in medical modelling and imaging, as well as in healthcare devices and equipment.

The Role of Digital Twins in Personalised Treatment

Traditional treatment approaches do not always take into account the differences, between patients. Digital twins can help address this challenge by modelling patient- characteristics and simulating how a person might respond to a particular therapy or medical device. This supports informed treatment planning. Of relying entirely on trial and error clinicians may be able to compare potential scenarios and identify approaches worth investigating further.

The benefits could extend to disease management, where treatment decisions often involve significant costs and uncertainty. Informed planning may also help healthcare organisations reduce avoidable complications and support value-based care models that focus on patient outcomes rather than procedure volumes.

Improving Medical Device Development and Clinical Planning

Digital twin technology is playing a role in the way medical devices are designed and evaluated. Virtual simulation permits manufacturers to be able to test a product's performance on different models of anatomy before it is further developed.  An example of this is The Living Heart Project by Dassault Systèmes. It was initially developed with the help of the US Food and Drug Administration.

It began as a validated cardiac model but has now changed into a more sophisticated platform that allows simulation for different patients. Hospitals also have the chance to use virtual models for rehearsals before the operations. For instance, Siemens Healthineers and Philips show how simulation is being used in the application of imaging and cardiac devices workflow.

Business Value and Governance Challenges

The opportunity for healthcare businesses is to spend less time to develop the devices, conduct research more efficiently, and possibly incur a lower cost of clinical development and care delivery. However, it all hinges on trustworthy patient data, valid models, and clinical validation.

Governance is never an afterthought and organisations require simple model version controls, auditing, validation protocols, delineation of responsibility between clinician and technical team. The safeguarding of patients' information and the ethical use of simulation results are non-negotiable.

Business Insight Journal and BI Journal continue to examine how emerging technologies influence healthcare strategy and investment. Readers can explore further industry perspectives through the BI Journal Inner Circle : https://bi-journal.com/the-inner-circle/ .

How Healthcare Organisations Can Adopt Digital Twins

Start by picking a high-value area, such as cardiology or orthopaedic device design. Organisations can validate the model measure the model’s operational value and expand into other areas as capabilities mature. This approach also requires collaboration across leadership, data science, engineering and finance. Digital twins are long-term investments so funding should reflect milestones rather, than short-term returns alone.

Conclusion

Digital twins of the human body are creating new possibilities for personalised treatment, medical research, and device development. Their real value lies in helping healthcare teams make better-informed decisions through simulation, rather than replacing clinical judgment.

Organisations that combine accurate models, strong data governance, and cross-functional investment will be better positioned to turn this technology into meaningful improvements in patient care and healthcare performance.

This business article is inspired by the insights and industry perspectives shared by Business Insight Journal: https://bi-journal.com/